How a single mycobacterial molecule reshapes immune cell fat

The immune system detects microbes through many pattern-recognition receptors, but how these receptors work together when they encounter a single complex microbial molecule is not well understood. In work led by Maria L Gennaro, researchers focused on macrophages, the immune cells that engulf pathogens and can turn into lipid-laden “foam cells” found in necrotizing tuberculosis lesions. Foam cells are notable for accumulating cytosolic lipid droplets filled with neutral lipids, and they are a hallmark of destructive lung lesions in tuberculosis. To learn what drives this dramatic change in macrophage metabolism, the team examined a major mycobacterial lipoglycan called mannose-capped lipoarabinomannan (ManLAM). Rather than acting through a single receptor, ManLAM was shown to engage more than one pattern-recognition receptor in a coordinated way. This finding frames foam cell formation not simply as a consequence of infection but as a programmed response set off by a specific mycobacterial component, offering a clearer picture of how innate immune sensing can redirect cell metabolism during Mycobacterium tuberculosis exposure.

The researchers found that ManLAM drives macrophage lipid droplet accumulation through combined activation of Toll-like receptor 2 (TLR2) and Dectin-2. Distinct structural moieties of ManLAM selectively mediate recognition by each receptor, indicating that different parts of the same molecule are read by different sensors. When both receptors are engaged, macrophages undergo lipid metabolic reprogramming and show enhanced NF-kB-mediated inflammatory signaling. Critically, the accumulation of neutral lipids proceeds through an mTORC1-PPARγ-dependent pathway that is largely independent of NF-kB activation, separating the metabolic outcome from the inflammatory transcriptional response. ManLAM-induced lipid changes closely mirror those seen during Mycobacterium tuberculosis infection in terms of neutral lipid composition and the same reliance on the mTORC1-PPARγ axis. Together, these results map a receptor-to-metabolism pathway linking dual receptor engagement by a single ligand to foam cell formation.

Identifying ManLAM as a major mycobacterial driver of foam cell-associated lipid metabolism has several important implications. First, it shows that the physical architecture of a complex microbial ligand can organize multi-receptor signaling and produce distinct downstream programs — in this case, a metabolic program that converts macrophages into lipid-storing foam cells. Second, by separating inflammatory signaling (NF-kB) from the lipid accumulation pathway (mTORC1-PPARγ), the work highlights specific molecular nodes that could be targeted to alter the metabolic fate of infected macrophages without necessarily suppressing inflammation. This refined understanding helps explain features of necrotizing tuberculosis lesions and points to new directions for research into how Mycobacterium tuberculosis manipulates host cells. Finally, the study suggests that interventions aimed at the mTORC1-PPARγ axis or at preventing dual TLR2 and Dectin-2 engagement by ManLAM might modulate foam cell formation during infection, offering a conceptual route to influence disease pathology.